InBody Co (XKRX:041830) Cash Flow for Dividends: ₩0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKRX:041830 InBody Co Ltd XKRX:041830
88 GF Score
Price ₩58,900.00
GF Value ₩35,473.99
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is InBody Co Cash Flow for Dividends?

InBody Co XKRX:041830 -3.60% 88 Cash Flow for Dividends is ₩0 Mil as of Jun. 2026. GuruFocus rates XKRX:041830 with a GF Score™ of 88/100 and a GF Value™ of ₩35,473.99 (Significantly Overvalued). The stock has 1 warning sign investors should review.

InBody Co's cash flow for dividends for the three months ended in Jun. 2026 was ₩0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Jun. 2026 was ₩0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

InBody Co's annual payment of dividends increased from Dec. 2023 (₩-3,908 Mil) to Dec. 2024 (₩-4,559 Mil) and increased from Dec. 2024 (₩-4,559 Mil) to Dec. 2025 (₩-5,043 Mil).

InBody Co Cash Flow for Dividends Related Terms

InBody Co Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for InBody Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InBody Co Cash Flow for Dividends Chart

InBody Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,823.76 -2,605.37 -3,908.05 -4,559.40 -5,043.18

InBody Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XKRX:041830
88GF Score
InBody Co Ltd XKRX:041830
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

InBody Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of ₩0 Mil mean?
InBody Co (XKRX:041830) has a Cash Flow for Dividends of ₩0 Mil as of Jun. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for InBody Co and its competitors.
Is InBody Co's Cash Flow for Dividends too high?
InBody Co's current Cash Flow for Dividends is ₩0 Mil. Overall, InBody Co has a GF Score™ of 88/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does InBody Co's Cash Flow for Dividends compare to ABT and SYK?
InBody Co's Cash Flow for Dividends of ₩0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Medical Devices & Instruments company?
A good Cash Flow for Dividends depends on the Medical Devices & Instruments industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for InBody Co and its competitors. InBody Co's current Cash Flow for Dividends is ₩0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InBody Co stock overvalued right now?
Based on GuruFocus' analysis, InBody Co (XKRX:041830) is currently considered Significantly Overvalued. The stock's GF Value™ is ₩35,473.99, compared to a current price of ₩58,900.00 — trading 66% above its estimated fair value. The current Cash Flow for Dividends is ₩0 Mil. InBody Co's overall GF Score™ is 88/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For InBody Co (XKRX:041830), the current Cash Flow for Dividends is ₩0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is InBody Co (XKRX:041830) Overvalued in 2026?

Based on GuruFocus' analysis, InBody Co stock appears to be overvalued. The current stock price of ₩58,900.00 is trading 66% above its estimated GF Value™ of ₩35,473.99. GuruFocus considers InBody Co to be Significantly Overvalued.

Key valuation signals for XKRX:041830:

  • Cash Flow for Dividends: ₩0 Mil
  • GF Value™: ₩35,473.99 vs. price of ₩58,900.00 (66% above fair value)
  • GF Score™: 88/100 with 1 warning sign

No single metric tells the full story. See the XKRX:041830 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

InBody Co Business Description

Address 54, Nonhyeon-ro 2-gil, Gangnam-gu, Seoul, KOR, 135-960
InBody Co Ltd is a Korea-based company engaged in the manufacturing and distribution of body composition analyzers. The company mainly produces body composition analyzers under the brand name InBody and Lookin'Body. It's InBody series products include InBody720, InBody570, InBody230, InBody J30, and InBody S10.
88GF Score

Get the complete analysis for XKRX:041830

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩58,900.00
Price
₩35,473.99
GF Value